NR
Nucleo provides automated AI technology to streamline clinical workflows in oncology care using CT scan analysis. The platform offers automatic quantification of body composition, precise tumor lesion sizing, and lesion classification based on RECIST criteria. This automation accelerates analysis compared to manual segmentation, improving consistency in diagnostic imaging review.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Nucleo provides automated AI technology to streamline clinical workflows in oncology care using CT scan analysis. The platform offers automatic quantification of body composition, precise tumor lesion sizing, and lesion classification based on RECIST criteria. This automation accelerates analysis compared to manual segmentation, improving consistency in diagnostic imaging review.